The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

Transcatheter Mitral Valve Repair: Coronary Sinus Annuloplasty Devices ... The stentless Direct Flow (Direct Flow Medical, Inc., CA, USA) valve. A trileaflet valve made from bovine pericardium ...

Mitral regurgitation is the most common form of valvular heart disease and affects around 10% of Americans over 75. It occurs when the mitral ...

The Irvine-based medical device maker today announced that it received CE mark approval for its Sapien M3 mitral replacement system.

Laplace Interventional, a US-based medical device company focusing on transcatheter ... of valve replacement procedures. The largest markets for these devices include aortic and mitral valve ...

--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...

Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up market rivalry with Abbott. Edwards’ device, dubbed Sapien M3 ...

Edwards SAPIEN M3 mitral valve replacement system receives CE Mark for transcatheter treatment: Irvine, California Wednesday, ...